| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3233/JAD-160324 |
| P698 | PubMed publication ID | 27497479 |
| P50 | author | Daniela Mari | Q30093174 |
| Carlo Abbate | Q57077651 | ||
| Cristina Gussago | Q59685512 | ||
| Martina Casati | Q64499148 | ||
| Evelyn Ferri | Q91754923 | ||
| Elena Colombo | Q98202564 | ||
| Paolo Dionigi Rossi | Q100417442 | ||
| Valeria Scortichini | Q117284251 | ||
| Beatrice Arosio | Q43088210 | ||
| P2860 | cites work | Adenosine receptors: therapeutic aspects for inflammatory and immune diseases | Q24651475 |
| Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity | Q24672753 | ||
| Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategies | Q28239158 | ||
| The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases | Q28293496 | ||
| Control of translation and mRNA degradation by miRNAs and siRNAs | Q29614239 | ||
| Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection | Q30307082 | ||
| The Dynamics and Turnover of Tau Aggregates in Cultured Cells: INSIGHTS INTO THERAPIES FOR TAUOPATHIES. | Q30780758 | ||
| Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly | Q33616120 | ||
| Increased prevalence of cardiovascular disease in idiopathic normal pressure hydrocephalus patients compared to a population-based cohort from the HUNT3 survey | Q34112908 | ||
| Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups | Q34156644 | ||
| gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia | Q34216896 | ||
| Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats | Q34485914 | ||
| Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus | Q34595719 | ||
| Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study | Q34603404 | ||
| Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo | Q35059150 | ||
| Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus | Q35123209 | ||
| Comparison between Alzheimer's disease and vascular dementia: Implications for treatment | Q35540384 | ||
| Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. | Q35698535 | ||
| Prion protein at the crossroads of physiology and disease. | Q35740063 | ||
| Epidemiology of Alzheimer disease | Q35920548 | ||
| Adenosine and adenine nucleotides as regulators of cerebral blood flow: roles of acidosis, cell swelling, and KATP channels | Q36111008 | ||
| Cholesterol: its regulation and role in central nervous system disorders | Q36355194 | ||
| Clinical aspects of inflammation in Alzheimer's disease | Q36364213 | ||
| Targeting cell death in dementia | Q36506185 | ||
| Purine and pyrimidine receptors | Q36765468 | ||
| Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. | Q53229484 | ||
| Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. | Q53354093 | ||
| Five-year incidence of surgery for idiopathic normal pressure hydrocephalus in Norway. | Q54533321 | ||
| The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. | Q54765467 | ||
| Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor. | Q55230640 | ||
| Erratum: A2A adenosine receptor deletion is protective in a mouse model of Tauopathy | Q57566967 | ||
| G-protein-coupled receptors: an update | Q36788551 | ||
| Physiology and pathophysiology of purinergic neurotransmission | Q36788894 | ||
| Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation | Q37006843 | ||
| Adenosine receptors and the central nervous system. | Q37565205 | ||
| Adenosine receptors and neurological disease: neuroprotection and neurodegeneration | Q37565211 | ||
| Differential regulation of microglial motility by ATP/ADP and adenosine | Q37677179 | ||
| Tuning and fine-tuning of synapses with adenosine. | Q37700201 | ||
| Prevalence of idiopathic normal-pressure hydrocephalus | Q37725895 | ||
| Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury | Q37863150 | ||
| Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature | Q37893201 | ||
| Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis | Q38045663 | ||
| The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease | Q38064315 | ||
| The cost of brain diseases: a burden or a challenge? | Q38221575 | ||
| Adenosine receptor control of cognition in normal and disease | Q38245141 | ||
| Neuropathology of older persons without cognitive impairment from two community-based studies | Q38405842 | ||
| Purinergic signalling in brain ischemia. | Q38637707 | ||
| The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists? | Q39490943 | ||
| The neuroprotective effects of caffeine: a prospective population study (the Three City Study). | Q39807488 | ||
| Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production | Q40238721 | ||
| Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade | Q40722338 | ||
| Global changes in DNA methylation in Alzheimer's disease peripheral blood mononuclear cells. | Q41752572 | ||
| GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions | Q42482067 | ||
| Adenosine A2A receptor expression in peripheral blood mononuclear cells of patients with mild cognitive impairment | Q43088167 | ||
| Association between milder brain deformation before a shunt operation and improvement in cognition and gait in idiopathic normal pressure hydrocephalus | Q43865077 | ||
| Blockade of A(2A) adenosine receptors leads to c-fos inhibition in a rat model of brain ischemia | Q43887494 | ||
| The effects of habitual caffeine use on cognitive change: a longitudinal perspective | Q44574451 | ||
| Blockade of adenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats. | Q46427356 | ||
| Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat. | Q46460712 | ||
| The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? | Q46516132 | ||
| Expression of adenosine A 2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-d-aspartate receptor currents | Q46578895 | ||
| Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease. | Q46778155 | ||
| Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 | ||
| Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony | Q48337623 | ||
| Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus | Q48348912 | ||
| Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice | Q48410779 | ||
| Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist | Q48420518 | ||
| Adenosine receptor agonists inhibit the release of gamma-aminobutyric acid (GABA) from the ischemic rat cerebral cortex | Q48469920 | ||
| Age, neuropathology, and dementia | Q48597534 | ||
| Pin1 contribution to Alzheimer's disease: transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer's disease. | Q48702462 | ||
| Asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in the elderly: a prospective study in a Japanese population | Q48840099 | ||
| Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery. | Q50717944 | ||
| Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study. | Q51913370 | ||
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| dementia | Q83030 | ||
| hydrocephalus | Q193003 | ||
| vascular dementia | Q583908 | ||
| idiopathic normal pressure hydrocephalus | Q28735834 | ||
| P304 | page(s) | 417-425 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target | |
| P478 | volume | 54 |
| Q64998166 | Adenosine A1 Receptor Agonist 2-chloro-N6-cyclopentyladenosine and Hippocampal Excitability During Brain Development in Rats. |
| Q45941531 | Quinazoline Carboxamides as Selective Antagonists of Adenosine 2A Receptor. |
| Q92114438 | Research progress on adenosine in central nervous system diseases |
| Q92394719 | Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases |
Search more.